These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34482543)
1. Non-negative blind deconvolution for signal processing in a CRISPR-edited iPSC-cardiomyocyte model of dilated cardiomyopathy. Xu H; Wali R; Cheruiyot C; Bodenschatz J; Hasenfuss G; Janshoff A; Habeck M; Ebert A FEBS Lett; 2021 Oct; 595(20):2544-2557. PubMed ID: 34482543 [TBL] [Abstract][Full Text] [Related]
2. Integrated machine learning and multimodal data fusion for patho-phenotypic feature recognition in iPSC models of dilated cardiomyopathy. Wali R; Xu H; Cheruiyot C; Saleem HN; Janshoff A; Habeck M; Ebert A Biol Chem; 2024 Jun; 405(6):427-439. PubMed ID: 38651266 [TBL] [Abstract][Full Text] [Related]
3. Integrated Ca Malkovskiy AV; Ignatyeva N; Dai Y; Hasenfuss G; Rajadas J; Ebert A Biol Chem; 2020 Nov; 402(1):113-121. PubMed ID: 33544492 [TBL] [Abstract][Full Text] [Related]
4. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients. Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807 [TBL] [Abstract][Full Text] [Related]
5. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes. Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626 [TBL] [Abstract][Full Text] [Related]
6. Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes. Lv W; Qiao L; Petrenko N; Li W; Owens AT; McDermott-Roe C; Musunuru K Circulation; 2018 Dec; 138(24):2852-2854. PubMed ID: 30565988 [No Abstract] [Full Text] [Related]
7. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy. Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000 [TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433 [TBL] [Abstract][Full Text] [Related]
9. 3D Computational Modeling of Defective Early Endosome Distribution in Human iPSC-Based Cardiomyopathy Models. Saleem HN; Ignatyeva N; Stuut C; Jakobs S; Habeck M; Ebert A Cells; 2024 May; 13(11):. PubMed ID: 38891055 [TBL] [Abstract][Full Text] [Related]
10. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells. Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046 [TBL] [Abstract][Full Text] [Related]
12. Increased cytosolic calcium buffering contributes to a cellular arrhythmogenic substrate in iPSC-cardiomyocytes from patients with dilated cardiomyopathy. Jung P; Seibertz F; Fakuade FE; Ignatyeva N; Sampathkumar S; Ritter M; Li H; Mason FE; Ebert A; Voigt N Basic Res Cardiol; 2022 May; 117(1):5. PubMed ID: 35499658 [TBL] [Abstract][Full Text] [Related]
13. Investigating Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639 [No Abstract] [Full Text] [Related]
14. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing. Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280 [TBL] [Abstract][Full Text] [Related]
15. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884 [TBL] [Abstract][Full Text] [Related]
16. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968 [TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model. Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583 [TBL] [Abstract][Full Text] [Related]
18. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035 [TBL] [Abstract][Full Text] [Related]
19. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes. Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948 [TBL] [Abstract][Full Text] [Related]
20. An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes. Dai Y; Ignatyeva N; Xu H; Wali R; Toischer K; Brandenburg S; Lenz C; Pronto J; Fakuade FE; Sossalla S; Zeisberg EM; Janshoff A; Kutschka I; Voigt N; Urlaub H; Rasmussen TB; Mogensen J; Lehnart SE; Hasenfuss G; Ebert A Circ Res; 2023 Jul; 133(2):e19-e46. PubMed ID: 37313752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]